Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning

Pediatric Transplantation

Volumn 19, Issue 1, 2015, Pages E25-E28

  Tsuma, Yusuke ^a,b   Imamura, Toshihiko ^a   Ichise, Eisuke ^a   Sakamoto, Kenichi ^a   Ouchi, Kazutaka ^a   Osone, Shinya ^a   Ishida, Hiroyuki ^a,c   Wada, Taizo ^d   Hosoi, Hajime ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYUSHU HOSPITAL   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^d KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

hematopoietic stem cell transplantation; idiopathic colitis; reduced intensity conditioning; XIAP deficiency

Indexed keywords

FLUDARABINE; MELPHALAN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY; TOCILIZUMAB; X LINKED INHIBITOR OF APOPTOSIS;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHILD; COLITIS; GRAFT VERSUS HOST REACTION; HUMAN; IDIOPATHIC DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; TREATMENT OUTCOME; X-LINKED LYMPHOPROLIFERATIVE DISEASE TYPE 2; ALLOTRANSPLANTATION; COMPLICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MULTIMODALITY CANCER THERAPY; REMISSION; X CHROMOSOME LINKED DISORDER;

CHILD; COLITIS; COMBINED MODALITY THERAPY; GENETIC DISEASES, X-LINKED; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84919797596     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12405     Document Type: Article

References (15)

1. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006: 444: 110-114.
2. Schmid JP, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 2011: 117: 1522-1529.
3. Yang X, Kanegane H, Nishida N, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol 2012: 32: 411-420.
4. Speckmann C, Lehmberg K, Albert MH, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol 2013: 149: 133-141.
5. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011: 13: 255-262.
6. Krieg A, Correa RG, Garrison JB, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci USA 2009: 106: 14524-14529.
7. Damgaard RB, Nachbur U, Yabal M, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 2012: 46: 746-758.
8. Damgaard RB, Fiil BK, Speckmann C, et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD-2 dependent immune signaling. EMBO Mol Med 2013: 5: 1278-1295.
9. Strober W, Watanabe T,. NOD2, an intracellular innate immune sensor involved in host defence and Crohn's disease. Mucosal Immunol 2011: 4: 484-495.
10. Zeissig Y, Petersen BS, Milutinovic S, et al. XIAP variants in male Crohn's disease. Gut 2014: doi: 10.1136/gutjnl-2013-306520.
11. Marsh RA, Rao K, Satwani P, et al. Allogeneic hematopoietic cell transplantation for XIAP deficiency: An international survey reveals poor outcomes. Blood 2013: 121: 877-883.
12. Zhao M, Kanegane H, Ouchi K, et al. A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica 2010: 95: 688-689.
13. Nishimoto N, Kishimoto T,. Interleukin 6: From bench to bedside. Nat Clin Pract Rheumatol 2006: 2: 619-626.
14. Ohga S, Kudo K, Ishi E, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010: 54: 299-306.
15. Jain S, Gozdziak P, Morgan A, et al. Remission of Crohn's disease after cord blood transplantation for leukocyte adhesion deficiency type 1. Bone Marrow Transplant 2013: 48: 1006-1007.